Managing BRCA Mutation Carriers
| Author | : | |
| Rating | : | 4.30 (749 Votes) |
| Asin | : | 3319591975 |
| Format Type | : | paperback |
| Number of Pages | : | 242 Pages |
| Publish Date | : | 2016-12-18 |
| Language | : | English |
DESCRIPTION:
It represents a valuable resource for a myriad of clinicians and healthcare personnel who interface with these patients. All chapters are written by experts in their fields and include the most up to date scientific and clinical information.. As there are a number of nuances in terms of how to manage mutation carriers (both with and without a concomitant diagnosis of breast cancer), this text provides a comprehensive, state-of-the art review of this field. The text discusses the latest recommendations for genetic counseling and risk assessment, provides a framework for considering reducing risk in mutation carriers who do not present with a concomitant diagnosis of breast cancer, and finally elucidates the many considerations of managing a breast cancer patient with a BRCA mutation. The text presents a multidisciplinary approach gleaning insights from imaging, breast surgery, gynecology, plastic surgery, medical oncology, radiation oncology and psycho-oncology.Managing BRCA Mutation Carriers will be a useful resource for physicians and healthcare providers from a myriad of disciplines who manage BRCA mutation carriers
It represents a valuable resource for a myriad of clinicians and healthcare personnel who interface with these patients. From the Back Cover As there are a number of nuances in terms of how to manage mutation carriers (both with and without a concomitant diagnosis of breast cancer), this text provides a comprehensive, state-of-the art review of this field. The text presents a multidisciplinary approach gleaning insights from imaging, breast surgery, gynecology, plastic surgery, medical oncology, radiation oncology and psycho-oncology.. The text discusses the latest recommendations for genetic counseling and risk assessment, provides a framework for considering reducing risk in mutation carriers who do not present with a concomitant diagnosis of breast cancer, and finally elucidates the many considerations of managing a breast cancer patient with a BRCA mutation